Loading...
Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
AIM: The purpose of this study was to treat burning mouth syndrome (BMS) with a combination of painful gabapentin and ultramicronized palmitoylethanolamide (umPEA), in an attempt to improve the severe symptomatology of BMS. METHODS: We examined the case of a 60-year-old male, suffering from late-ons...
Na minha lista:
| Udgivet i: | Int Med Case Rep J |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6385774/ https://ncbi.nlm.nih.gov/pubmed/30858732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S194403 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|